SFY 2018 - 2019 MC MLR Report Summary
HIV SNP line of business
- Report also available in Portable Document Format (PDF)
| SFY 2018 - 2019 MC MLR Report Summary | |||||||
|---|---|---|---|---|---|---|---|
| HIV SNP line of business | |||||||
| Plan | MLR AFTER Credibility Adjustment |
Medical Expense (Total Numerator) |
Premium (Total Denominator) |
Remittance | Credible | MMs | |
| Amida Care Inc. | 90.72% | $381,455,844 | $431,224,382 | $0 | Partially Credible | 81,926 | |
| MetroPlus Health Plan, Inc | 95.93% | $205,200,138 | $220,494,590 | $0 | Partially Credible | 49,617 | |
| VNS (d/b/a VNSNY Choice) and Subsidiary | 89.06% | $174,835,837 | $203,886,112 | $0 | Partially Credible | 39,193 | |
| Total | $761,491,819 | $855,605,084 | $0 | 170,736 | |||
NOTES:
Please note that the Remittance is for this line of business for one year ONLY based on a MLR Target of 86%.
No remittance for plan if Non-Credible
